These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36294302)

  • 21. Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Concistrè A; Petramala L; Scoccia G; Sciomer S; Bisogni V; Saracino V; Iannucci G; Lai S; Mastroluca D; Iacobellis G; Letizia C
    Cardiorenal Med; 2018; 8(3):199-207. PubMed ID: 29723863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
    Pietrzak-Nowacka M; Safranow K; Czechowska M; Dutkiewicz G; Kornacewicz-Jach Z; Ciechanowski K
    Kidney Blood Press Res; 2012; 36(1):301-9. PubMed ID: 23235185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of echocardiographic abnormalities in mucopolysaccharidosis III.
    Wilhelm CM; Truxal KV; McBride KL; Kovalchin JP; Flanigan KM
    Mol Genet Metab; 2018 Jun; 124(2):131-134. PubMed ID: 29735373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Outcomes in Kidney Transplant Recipients With ADPKD.
    Chedid M; Kaidbay HD; Wigerinck S; Mkhaimer Y; Smith B; Zubidat D; Sekhon I; Prajwal R; Duriseti P; Issa N; Zoghby ZM; Hanna C; Senum SR; Harris PC; Hickson LJ; Torres VE; Nkomo VT; Chebib FT
    Kidney Int Rep; 2022 Sep; 7(9):1991-2005. PubMed ID: 36090485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
    Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
    J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
    De Almeida EA; Prata MM
    Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
    Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
    Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pathophysiology of Left Ventricular Hypertrophy, beyond Hypertension, in Autosomal Dominant Polycystic Kidney Disease.
    Oto OA; Edelstein CL
    Nephron; 2024; 148(4):215-223. PubMed ID: 35896062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
    Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does early surgical intervention improve left ventricular mass regression after mitral valve repair for leaflet prolapse?
    Stulak JM; Suri RM; Dearani JA; Burkhart HM; Sundt TM; Enriquez-Sarano M; Schaff HV
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):122-9. PubMed ID: 21168021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
    Karava V; Benzouid C; Hogan J; Dossier C; Denjean AP; Deschênes G
    Pediatr Nephrol; 2018 Sep; 33(9):1513-1521. PubMed ID: 29774463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
    Perrone RD; Abebe KZ; Schrier RW; Chapman AB; Torres VE; Bost J; Kaya D; Miskulin DC; Steinman TI; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Kelleher C; Masoumi A; Glockner J; Halin NJ; Martin D; Remer E; Patel N; Pedrosa I; Wetzel LH; Thompson PA; Miller JP; Bae KT; ; Meyers CM
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2508-15. PubMed ID: 21903983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
    Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
    Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Body Fat and Organic Acid Anions Production Are Associated with Larger Kidney Size in ADPKD.
    Dos Santos Dutra A; Rodrigues FG; da Rocha DR; Vendramini LC; de Matos ACC; Heilberg IP
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208476
    [No Abstract]   [Full Text] [Related]  

  • 35. Ultrasonic characterization (integrated backscatter) of myocardial tissue in patients with autosomal dominant polycystic kidney disease.
    Jin X; Rong S; Mei C; Chen J; Ye C; Chen X
    Nephron Clin Pract; 2010; 114(4):c288-94. PubMed ID: 20090371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson AM; Rainguet S; Hossack K; Gabow P; Schrier RW
    J Am Soc Nephrol; 1997 Aug; 8(8):1292-7. PubMed ID: 9259356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow up of a boy with unilateral autosomal dominant polycystic kidney disease and contralateral renal agenesis.
    Krzemień G; Turczyn A; Pańczyk-Tomaszewska M; Jakimów-Kostrzewa A; Szmigielska A
    Dev Period Med; 2017; 21(4):380-383. PubMed ID: 29291365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echocardiographic findings in autosomal dominant polycystic kidney disease.
    Hossack KF; Leddy CL; Johnson AM; Schrier RW; Gabow PA
    N Engl J Med; 1988 Oct; 319(14):907-12. PubMed ID: 3419455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience.
    Rabbani MA; Ali SS; Murtaza G; Ahmad B; Maria Q; Siddiqui BK; Shah SM; Ahmad A
    J Pak Med Assoc; 2008 Jun; 58(6):305-9. PubMed ID: 18988388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.